Skip to content

Now providing Mesenchymal cell-based immunomodulation for Covid19-induced hypercytokinemia. Contact us to learn more

Somata
Genesis Biopharmaceuticals
  • Covid-19
    • Clinical Trials
    • Products
      • Ventilator
  • Treatments
    • Neurodegenerative Diseases
      • Multiple sclerosis
      • Amyotrophic lateral sclerosis
      • Parkinson’s disease
      • Cerebral palsy
      • Autism
    • Diabetes T2
    • Critical limb ischemia
    • Kidney disorder
    • Stroke
  • Biopharmaceuticals
    • Neutrojen
    • Somajen
    • Stem cells
  • Services
    • Bioequivalence
    • Pharmacokinetics
  • Discoveries
    • Multiple Sclerosis
    • COVID-19
  • Contact

COVID-19 Resource

Autoimmune Patients
Autoimmune Patients
Pathogenesis
Pathogenesis
SARS-CoV2
SARS-CoV2
Symptoms
Symptoms
Treatments
Treatments
Vaccine
Vaccine
https://www.facebook.com/somatagenesis
500 E 10th St., Burley, Idaho 83318, USA
USA Tollfree 1 844 518 9699
International +1 646 583 1660
info@somatagenesis.com
  • Neutrojen
  • Somajen
  • Stem cells
  • Bioequivalence
  • Contact
  • COVID-19
  • Multiple Sclerosis Research
Copyright © 2023 Somata Genesis, Inc. | 500 E 10th St., Burley, Idaho 83318, USA
  • Facebook
  • LinkedIn
  • Twitter